BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37459191)

  • 1. What's the Catch? The Significance of Catch Bonds in T Cell Activation.
    Faust MA; Rasé VJ; Lamb TJ; Evavold BD
    J Immunol; 2023 Aug; 211(3):333-342. PubMed ID: 37459191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition.
    Wu P; Zhang T; Liu B; Fei P; Cui L; Qin R; Zhu H; Yao D; Martinez RJ; Hu W; An C; Zhang Y; Liu J; Shi J; Fan J; Yin W; Sun J; Zhou C; Zeng X; Xu C; Wang J; Evavold BD; Zhu C; Chen W; Lou J
    Mol Cell; 2019 Mar; 73(5):1015-1027.e7. PubMed ID: 30711376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.
    Sibener LV; Fernandes RA; Kolawole EM; Carbone CB; Liu F; McAffee D; Birnbaum ME; Yang X; Su LF; Yu W; Dong S; Gee MH; Jude KM; Davis MM; Groves JT; Goddard WA; Heath JR; Evavold BD; Vale RD; Garcia KC
    Cell; 2018 Jul; 174(3):672-687.e27. PubMed ID: 30053426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptors, mechanosensors, catch bonds and immunotherapy.
    Wang JH
    Prog Biophys Mol Biol; 2020 Jul; 153():23-27. PubMed ID: 32006526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical forces impair antigen discrimination by reducing differences in T-cell receptor/peptide-MHC off-rates.
    Pettmann J; Awada L; Różycki B; Huhn A; Faour S; Kutuzov M; Limozin L; Weikl TR; van der Merwe PA; Robert P; Dushek O
    EMBO J; 2023 Apr; 42(7):e111841. PubMed ID: 36484367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling.
    Liu B; Chen W; Evavold BD; Zhu C
    Cell; 2014 Apr; 157(2):357-368. PubMed ID: 24725404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent TCR-peptide-MHC interactions induce T cell activation and redirect T cell fate in the thymus.
    Szeto C; Zareie P; Wirasinha RC; Zhang JB; Nguyen AT; Riboldi-Tunnicliffe A; La Gruta NL; Gras S; Daley SR
    Nat Commun; 2022 Aug; 13(1):4951. PubMed ID: 35999236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
    Aleksic M; Dushek O; Zhang H; Shenderov E; Chen JL; Cerundolo V; Coombs D; van der Merwe PA
    Immunity; 2010 Feb; 32(2):163-74. PubMed ID: 20137987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity.
    Rushdi MN; Pan V; Li K; Choi HK; Travaglino S; Hong J; Griffitts F; Agnihotri P; Mariuzza RA; Ke Y; Zhu C
    Nat Commun; 2022 Nov; 13(1):7055. PubMed ID: 36396644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is TCR/pMHC Affinity a Good Estimate of the T-cell Response? An Answer Based on Predictions From 12 Phenotypic Models.
    Gálvez J; Gálvez JJ; García-Peñarrubia P
    Front Immunol; 2019; 10():349. PubMed ID: 30886616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 preferentially inhibits the activation of low-affinity T cells.
    Shimizu K; Sugiura D; Okazaki IM; Maruhashi T; Takemoto T; Okazaki T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34433672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell antigen recognition: catch-as-catch-can or catch-22?
    Huppa JB; Schütz GJ
    EMBO J; 2023 Apr; 42(7):e113507. PubMed ID: 36808636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-pMHC kinetics under force in a cell-free system show no intrinsic catch bond, but a minimal encounter duration before binding.
    Limozin L; Bridge M; Bongrand P; Dushek O; van der Merwe PA; Robert P
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16943-16948. PubMed ID: 31315981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of 2D Affinity to T Cell Functional Outcomes.
    Kolawole EM; Lamb TJ; Evavold BD
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.
    Kolawole EM; Andargachew R; Liu B; Jacobs JR; Evavold BD
    Front Immunol; 2018; 9():2348. PubMed ID: 30374353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanobiology of T Cell Activation: To Catch a Bond.
    Liu B; Kolawole EM; Evavold BD
    Annu Rev Cell Dev Biol; 2021 Oct; 37():65-87. PubMed ID: 34213954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.
    Dhusia K; Su Z; Wu Y
    Mol Immunol; 2021 Nov; 139():76-86. PubMed ID: 34455212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.